Deerfield Management key facts
- Deerfield Management is a venture capital firm based in New York, New York with 39 tracked portfolio companies.
- Notable positions include Blink Health, InSilico Medicine Cayman (HKG: 03696), Parabilis Medicines.
- PrivateMarketView records 3 deal participations by Deerfield Management.
- Deerfield Management’s most recent recorded investment was in May 2025 and 1 over two years.
- Deerfield Management has 1 fund on record.
- The team roster lists 1 person.
About Deerfield Management
Founded in 1994, Deerfield Management is a venture capital firm based in New York. The firm seeks to invest in companies operating in healthcare products and services. The firm is a Registered Investment Adviser (RIA).
Investment activity
Deerfield Management joined 1 recorded round in the last two years, in line with the 1 in the two years before. By year: 1 in 2025, 1 in 2024 and 1 in 2022. Deerfield Management is recorded as lead on 1 of them. Deerfield Management most often invests alongside Define Ventures (3 shared rounds), Flare Capital Partners (3 shared rounds) and Longitude Capital (3 shared rounds). Most recently: Cohere Health (Series C, May 2025) and Cohere Health (Series B, Feb 2024).
Deerfield Management portfolio at a glance
39 portfolio companies are on record for Deerfield Management, including Blink Health, InSilico Medicine Cayman (HKG: 03696) and Parabilis Medicines.
28 of the 39 carry a recorded valuation.
Deerfield Management funds
1 fund is on record for Deerfield Management. The most recent is Flare Capital Partners II (Flare Capital Partners).
Deerfield Management team
1 person is on record at Deerfield Management. Senior names include Jonathan Isler (Partner). 1 of them have a verified direct contact on file.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Deerfield Management at the SEC
Form ADV · 2026-03 · CRD 104964- Regulatory AUM
- —
- Private fund assets
- —
- Private funds
- —
- Staff
- 14
- Registered office
- INDIANAPOLIS, IN
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as DEERFIELD FINANCIAL ADVISORS, INC.).
- ·The top 10 names in the book — of 39 recorded positions
- ·Watchlist + alerts for Deerfield Management's activity
Portfolio
39 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Blink Health | — | ▮ | ▮ | ▮ |
| InSilico Medicine Cayman (HKG: 03696) | Biotech | ▮ | ▮ | ▮ |
| Parabilis Medicines | Drug Discovery | ▮ | ▮ | ▮ |
+ 36 more companies · all 39, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Deerfield Management recent deals
3 recordedMembership and data by Private Market View
Funds
1 recorded- Flare Capital Partners II (Flare Capital Partners)—
Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.
Frequently asked about Deerfield Management
- What companies does Deerfield Management invest in?
- Deerfield Management has 39 recorded portfolio companies, including Blink Health, InSilico Medicine Cayman (HKG: 03696), Parabilis Medicines.
- What is Deerfield Management's AUM?
- Deerfield Management manages approximately $15.0B in assets.
- Is Deerfield Management actively investing?
- Deerfield Management's most recent recorded investment was in May 2025.